PL355442A1 - Analogi podstawionego homopiperydynylobenzimidazolu jako środki posiadające właściwości wiotczenia dna żołądka - Google Patents

Analogi podstawionego homopiperydynylobenzimidazolu jako środki posiadające właściwości wiotczenia dna żołądka

Info

Publication number
PL355442A1
PL355442A1 PL00355442A PL35544200A PL355442A1 PL 355442 A1 PL355442 A1 PL 355442A1 PL 00355442 A PL00355442 A PL 00355442A PL 35544200 A PL35544200 A PL 35544200A PL 355442 A1 PL355442 A1 PL 355442A1
Authority
PL
Poland
Prior art keywords
fundic
relaxants
benzimidazole analogues
substituted homopiperidinyl
substituted
Prior art date
Application number
PL00355442A
Other languages
English (en)
Other versions
PL199678B1 (pl
Inventor
Frans Eduard Janssens
Jerome Emile Georges Guillemont
Francois Maria Sommen
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of PL355442A1 publication Critical patent/PL355442A1/pl
Publication of PL199678B1 publication Critical patent/PL199678B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cosmetics (AREA)
PL355442A 1999-12-21 2000-12-14 Analog podstawionego homopiperydynylobenzimidazolu jako środek posiadający właściwości wiotczenia dna żołądka i sposób jego otrzymywania oraz kompozycja farmaceutyczna i sposób jej otrzymywania PL199678B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204441 1999-12-21
PCT/EP2000/012858 WO2001046189A1 (en) 1999-12-21 2000-12-14 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants

Publications (2)

Publication Number Publication Date
PL355442A1 true PL355442A1 (pl) 2004-04-19
PL199678B1 PL199678B1 (pl) 2008-10-31

Family

ID=8241040

Family Applications (1)

Application Number Title Priority Date Filing Date
PL355442A PL199678B1 (pl) 1999-12-21 2000-12-14 Analog podstawionego homopiperydynylobenzimidazolu jako środek posiadający właściwości wiotczenia dna żołądka i sposób jego otrzymywania oraz kompozycja farmaceutyczna i sposób jej otrzymywania

Country Status (33)

Country Link
US (1) US7304052B2 (pl)
EP (1) EP1250337B1 (pl)
JP (1) JP4852210B2 (pl)
KR (1) KR100715351B1 (pl)
CN (1) CN100343251C (pl)
AT (1) ATE416174T1 (pl)
AU (1) AU781144B2 (pl)
BG (1) BG65784B1 (pl)
BR (1) BRPI0016638B8 (pl)
CA (1) CA2393158C (pl)
CY (1) CY1108844T1 (pl)
CZ (1) CZ299803B6 (pl)
DE (1) DE60041001D1 (pl)
DK (1) DK1250337T3 (pl)
EA (1) EA005851B1 (pl)
EE (1) EE05182B1 (pl)
ES (1) ES2317856T3 (pl)
HK (1) HK1053109B (pl)
HR (1) HRP20020518B1 (pl)
HU (1) HU229929B1 (pl)
IL (2) IL150310A0 (pl)
MX (1) MXPA02006346A (pl)
MY (1) MY127758A (pl)
NO (1) NO322362B1 (pl)
NZ (1) NZ518816A (pl)
PL (1) PL199678B1 (pl)
PT (1) PT1250337E (pl)
SI (1) SI1250337T1 (pl)
SK (1) SK287113B6 (pl)
TW (1) TWI225488B (pl)
UA (1) UA73963C2 (pl)
WO (1) WO2001046189A1 (pl)
ZA (1) ZA200204983B (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
US7160879B2 (en) 2002-01-10 2007-01-09 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analogues
CN100567270C (zh) * 2004-02-19 2009-12-09 万有制药株式会社 磺酰胺衍生物
MX2009007912A (es) * 2007-01-25 2009-07-31 Janssen Pharmaceutica Nv Derivados de 2-piperazin-1-il-3h-imidazo[4,5-b]piridina.
PT3012258T (pt) 2010-06-24 2018-12-14 Gilead Sciences Inc Composição farmacêutica compreendendo um derivado de pirazolo[1,5-a]pirimidina como agente antiviral
EP2643304A2 (en) * 2010-11-24 2013-10-02 Sequent Scientific Ltd. A process for preparation of albendazole
JP2014159375A (ja) * 2011-06-15 2014-09-04 Takeda Chem Ind Ltd アゼパン化合物
JP6122868B2 (ja) 2011-12-22 2017-04-26 ギリアード サイエンシーズ， インコーポレイテッド 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン
AU2013249280B2 (en) 2012-04-17 2017-10-12 Gilead Sciences, Inc. Compounds and methods for antiviral treatment
WO2015091584A1 (en) * 2013-12-18 2015-06-25 F. Hoffmann-La Roche Ag Thiazolopyridine compounds, compositions and their use as tyk2 kinase inhibitors
WO2019110703A1 (en) * 2017-12-08 2019-06-13 Boehringer Ingelheim International Gmbh Imidazopyridine derivatives and the use thereof as medicament

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060197C3 (de) * 1970-12-08 1979-02-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von 2-Aminobenzothiazol und dessen N-Alkylsubstitutionsprodukten
US4093726A (en) * 1976-12-02 1978-06-06 Abbott Laboratories N-(2-benzimidazolyl)-piperazines
ES8101067A1 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
JPS5879983A (ja) * 1981-11-06 1983-05-13 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
FR2528526A1 (fr) * 1982-06-09 1983-12-16 Sfr Sa Robinetterie Butee se fixant dans un alesage d'un dispositif
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE3634066A1 (de) * 1986-10-07 1988-04-21 Boehringer Mannheim Gmbh Neue 5-alkylbenzimidazole, verfahren zu ihrer herstellung sowie arzneimittel
JPH0260197A (ja) * 1988-08-26 1990-02-28 Nec Corp パッケージ構造
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
IL101851A (en) * 1991-06-13 1996-05-14 Janssen Pharmaceutica Nv 10-(4-piperidinyl- and piperidinylidene)-imidazo [1,2-a] (pyrrolo thieno or furano) [2,3] azepine derivatives their preparation and pharmaceutical compositions containing them and certain novel intermediates therefor
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
KR950702416A (ko) * 1992-07-08 1995-07-29 제임스 클리프튼 보올딩 돼지에서 위궤양을 완화시키기 위한 벤즈이미다졸(Benzimidazoles for alloviating stomach ulcers in swine)
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
EP0711768B1 (en) * 1994-05-31 2002-02-13 Mitsui Chemicals, Inc. Benzimidazole derivative
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6150379A (en) * 1997-11-26 2000-11-21 Axys Pharmaceuticals, Inc. Compounds and compositions as anticoagulants
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues

Also Published As

Publication number Publication date
EA200200700A1 (ru) 2003-06-26
SK287113B6 (sk) 2009-12-07
AU781144B2 (en) 2005-05-05
JP4852210B2 (ja) 2012-01-11
HRP20020518A2 (en) 2004-08-31
CN1411460A (zh) 2003-04-16
AU2167301A (en) 2001-07-03
PT1250337E (pt) 2009-03-05
NO20022977L (no) 2002-08-08
EP1250337B1 (en) 2008-12-03
PL199678B1 (pl) 2008-10-31
IL150310A (en) 2008-07-08
BG106749A (en) 2003-01-31
UA73963C2 (uk) 2005-10-17
TWI225488B (en) 2004-12-21
CA2393158A1 (en) 2001-06-28
HK1053109A1 (zh) 2003-10-10
CN100343251C (zh) 2007-10-17
EE05182B1 (et) 2009-06-15
KR100715351B1 (ko) 2007-05-08
MXPA02006346A (es) 2002-12-13
EA005851B1 (ru) 2005-06-30
KR20020062643A (ko) 2002-07-26
HK1053109B (zh) 2008-08-01
ZA200204983B (en) 2003-09-22
CZ299803B6 (cs) 2008-12-03
ATE416174T1 (de) 2008-12-15
MY127758A (en) 2006-12-29
NO322362B1 (no) 2006-09-25
HUP0203847A3 (en) 2004-07-28
WO2001046189A1 (en) 2001-06-28
CY1108844T1 (el) 2014-07-02
SI1250337T1 (sl) 2009-04-30
HU229929B1 (en) 2015-01-28
SK8542002A3 (en) 2003-07-01
EE200200326A (et) 2003-10-15
US20030139393A1 (en) 2003-07-24
EP1250337A1 (en) 2002-10-23
JP2003518118A (ja) 2003-06-03
DE60041001D1 (de) 2009-01-15
US7304052B2 (en) 2007-12-04
ES2317856T3 (es) 2009-05-01
HUP0203847A2 (hu) 2003-03-28
NZ518816A (en) 2003-01-31
CA2393158C (en) 2010-10-19
BR0016638B1 (pt) 2013-02-05
NO20022977D0 (no) 2002-06-20
BRPI0016638B8 (pt) 2017-04-25
CZ20022055A3 (cs) 2003-06-18
HRP20020518B1 (en) 2009-02-28
BR0016638A (pt) 2002-10-01
DK1250337T3 (da) 2009-03-30
BG65784B1 (bg) 2009-11-30
IL150310A0 (en) 2002-12-01

Similar Documents

Publication Publication Date Title
MY132129A (en) Polyarylcarboxamides useful as lipid lowering agents
PL351470A1 (en) Tri-aryl acid derivatives as ppar receptor ligands
PT1448853E (pt) Melhoramentos relacionados com branqueadores ópticos
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
BG106585A (en) Kinase inhibitors as therapeutic agents
DE60112609D1 (en) Pyrazolopyridine
AU2003228770A8 (en) Substituted pyrazolopyrimidines
YU3902A (sh) Imidazoimidazoli i triazoli kao anti-inflamatorna sredstva
TR200000333T2 (tr) Y alıcı antagonistleri olarak 4-aminopirol (3,2-d) pirimidinler.
MXPA03006605A (es) Esteres de indol-5-ilo del acido bencensulfonico como antagonistas del receptor 5-ht6.
DE60112330D1 (en) Pyrazolopyridinderivate
IL150310A0 (en) Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
TR200002932T2 (tr) Azabisayklik 5HT1 Alıcı liganolları
UA66866C2 (uk) Синтез морфолінових похідних
BG105847A (en) Calcilytic compounds
GR1002883B (el) Νεα παραγωγα της 2, 3-βενζοδιαζεπινης
TR200102501T2 (tr) Antiviral nükleozid analoglar.
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
DE60201074D1 (en) Pyrazolopyridinderivate
ATE251162T1 (de) Triazolo(4,5-d)pyrimidin-verbindungen
TR200200494T2 (tr) Yağlı asit sintazı inhibitörleri.
SE9604582D0 (sv) Novel compounds
MA25072A1 (fr) PROCEDES PERFECTIONNéS POUR LA PREPARATION SECRETAGOGUES D'HORMONES DE CROISSANCE
DE60100539D1 (en) Tosylprolin-derivate als thymidylat-synthase inhibitoren